Zdrowie i gospodarka · 30/05/2014

FDA Reclassifies Nucleic Acid-Based Devices for Tuberculosis Detection

The FDA is reclassifying nucleic acid-based in vitro diagnostic devices for detecting Mycobacterium tuberculosis complex in respiratory specimens from class III to class II, with the issuance of special controls guidelines to aid in pulmonary tuberculosis diagnosis.